Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Research

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

EASD: New EASD/ADA Position Paper Shifts Treatment Goals with 7 Key Points Posted: Tuesday, October 09, 2012

A new position statement for treatment of type 2 diabetes treatment focuses on the individual patient rather than a "one number fits all" HbA1c target.

EASD: Once a Year Exenatide Introduced at EASD Posted: Monday, October 08, 2012

Continuous long-term delivery of exenatide with Intarcia's osmotic mini-pump system allows optimal dose selection for improved glycemic control, ensures adherence, and improves patient tolerability.

EASD: Merck's Investigational Once-Weekly DPP-4 Inhibitor Significantly Lowered Blood Sugar in Patients with Type 2 Diabetes Posted: Monday, October 08, 2012

Merck announced Phase IIb data for MK-3102, the company's investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes.

L-cysteine a Possible Therapy for Type-2 Diabetes Posted: Tuesday, October 02, 2012

Taking L-cysteine supplements may help patients with type 2 diabetes better control blood sugar levels.

Using Antibiotics in Babies May Increase Risk for Obesity and Diabetes Posted: Friday, August 31, 2012

New research suggests that giving babies antibiotics between the ages of 10 months and 3 years may increase their chances of being overweight in childhood.

Death Risk Drops by 50% for Diabetes Patients Using Statins Posted: Thursday, August 30, 2012

Type 2 diabetes patients on statin drugs have lower mortality risk.

New Strategies for Diabetes Treatment Posted: Saturday, July 14, 2012

Researchers are trying new approaches to treat type 2 diabetes amid widespread uncertainty about the most effective therapies and concerns that current strategies might be doing some patients more harm than good.

A New Diabetes Drug Improves Blood Sugar Posted: Saturday, July 07, 2012

Gevokizumab, a new diabetes drug, may improve fluctuations in blood sugar and reduce inflammation in patients with type 2 diabetes....

Diabetes Patients' Use of Aspirin May Not Be Effective Posted: Monday, July 02, 2012

Many patients with type 2 diabetes may be aspirin resistant and a standard aspirin dose may not protect them against blood clots that can cause heart attacks and strokes....

Sulfonylureas Increase Mortality by 50 Percent Posted: Sunday, July 01, 2012

Data from a large retrospective cohort study suggested that, diabetic patients treated with three commonly prescribed sulfonylurea drugs had a 50% higher mortality risk compared with patients treated with metformin....

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.